Final exam of Tharini Ashtalakshmi Selvakumar June 4, After graduation, he first worked as a medical assistant in the Department of Cardiothoracic, Transplantation and Vascular Surgery at the MHH, before he took over the clinical management of this department in His translational work aims at improving molecular diagnostics, cellular immunotherapy, as well as stem cell, tissue and organ transplantation. Since , she is group leader with major interests in blood pharming large-scale in vitro production of blood cell components and the reduction of immunogenicity of allogeneic cell-based products to prevent rejection after transplantation. In Christoph Priesner changed to a biotech company in Hannover as a team leader and later Head of Quality Control and Qualified Person, involved in the development and manufacture of medicinal standard products as well as of advanced therapy investigational medicinal products ATIMP , both derived from human tissue and blood. Her research is mainly concerned with the formulation of poorly water soluble drug substances by employing nanoparticulate and nanostructured delivery systems.
Based on these knowledge alternative in vitro models are developed e. Schilling examines — in addition to questions regarding clinical management and health economics — the development of bioartificial heart muscle and aortic replacements, in close cooperation with the Leibniz University Hannover. Christoph Priesner studied biology at the University of Bielefeld und graduated at its Technical Faculty on industrial up- und downstream processing of monoclonal antibodies. Schilling is the author of numerous publications and book chapters and has an experience of more than scientific presentations and product presentations. In his own group, he is currently investigating antiviral immunity and viral immune evasion.
He is an expert in oligonucleotides pharmacology, biomarker development and experienced in industry sponsored drug development collaborations. After his doctoral thesis Institute of Zoology, TiHo he worked as contract researcher and gained experiences in the field of studies for pharmaceutical and biomedical industry under GLP conditions.
Corlife is a developer and manufacturer of medicinal products tissue preparations and medical devices for cardiovascular surgery www. His recent focus is on translational non-coding RNA 200 and development of microRNA therapeutics in heart failure.
In Christoph Priesner changed to a biotech company in Hannover as a team leader and later Head of Quality Control and Qualified Person, involved in the development and manufacture of medicinal standard products as well as of advanced therapy investigational medicinal products ATIMPboth derived from human tissue and blood. In addition to conducting translational research projects, he contributes to the development of new teaching formats on regulatory issues that are relevant in the conduct of clinical trials.
Marcel Mertz has studied philosophy and sociology at the University of Basel and gained his PhD in philosophy at the University of Mannheim.
Final exam of Eugenia Gripp June didsertation, Here, the generation of patient- and disease-specific induced dissertatio cells as an indefinite reservoir becomes increasingly important potentially creating the perspective of genetic correction and cell fate modification of stem and progenitor cells for combined cell and gene therapy in selected applications. In his own group, he is currently investigating antiviral immunity and viral immune evasion.
Final exam of Katharina Borst June 26, Schilling examines — in addition to questions regarding clinical management and health economics — the development of bioartificial heart muscle and aortic replacements, in close cooperation with the Leibniz University Hannover.
MH-Hannover: Thesis submission
His research focusses on chemoinformatics and chemometrics. You can only see the contact information of the academics in the disesrtation if you are a registered user of AcademiaNet.
Habilitation postdoctoral qualification disseetation venia legendi authorisation to teach in regenerative medicine at MHH, thesis titled: There he formed a group for Environmental Genetics and was able to finance a significant part of it by acquiring third party funding. Periostin secreted by mesenchymal stem cells supports tendon formation in an ectopic mouse model. Regenerative Medizin “Regenerative Medicine”. One further, but closely related focus of her work includes dissertagion quality control for Somatic Cell Therapy as well as Gene Therapy products, the determination of functional capability and multivariate immune reconstitution models to optimize the time points for cell-based therapies.
There he investigated the role of CD8 as a co-receptor in the specific T mhg recognition and aspects of peripheral T cell tolerance. Final exam of Stephanie Trittel June 15, During a postdoctoral and research assistant phase and at the University Hospital of Zurich, he worked in the laboratory of Nobel laureate Rolf Zinkernagel.
Schilling dealt both analytically and operationally with research communication. Furthermore, he has done research in clinical ethics, i.
Speakers | Nephrology Congress | Worldwide Events | Kidney conferences
Speakers from A to Z. She has been managing partner since then. Final exam of Sebastian Lunemann on January 22, Inhe was appointed head of quality control according to German drug law. Primary school, gymnasium dissertatiob school in Hannover, Germany; awarded the Abitur A-levels with top marks 1,0. Reviewer for journals e.
Gerdelmann holds certificates as quality manager and auditor. Moreover, as quality management representative he supports the introduction of a quality management system according to ISO at the Department of Otolaryngology which is planned for Final exam of Dissertation Kiene on February 4, Final exam of Anne Frentzen on July 22, Final exam of Maxi Scheiter on July 12, Stem Cells Dev ; 23 Evidence for “Brain-Type” N-Glycosylation.